| scholarly article | Q13442814 |
| P356 | DOI | 10.1080/09273948.2016.1276933 |
| P698 | PubMed publication ID | 28146363 |
| P50 | author | Andrea Leonardi | Q87781040 |
| Christophe Baudouin | Q37616711 | ||
| P2093 | author name string | Bruno Flamion | |
| P2860 | cites work | Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications | Q43482891 |
| Value-based medicine, comparative effectiveness, and cost-effectiveness analysis of topical cyclosporine for the treatment of dry eye syndrome | Q44006693 | ||
| A new approach for better comprehension of diseases of the ocular surface | Q44020701 | ||
| Evaluation of tear osmolarity in non-Sjögren and Sjögren Syndrome dry eye patients with the TearLab system | Q44079212 | ||
| Evaluation of topical cyclosporine for the treatment of dry eye disease | Q44443222 | ||
| The lack of association between signs and symptoms in patients with dry eye disease | Q45122466 | ||
| A link between tear instability and hyperosmolarity in dry eye. | Q46072952 | ||
| An objective approach to dry eye disease severity | Q48343172 | ||
| Long-term resolution of chronic dry eye symptoms and signs after topical cyclosporine treatment. | Q48648762 | ||
| The effect of decreasing the dosage of cyclosporine A 0.05% on dry eye disease after 1 year of twice-daily therapy. | Q50524947 | ||
| Performance of tear osmolarity compared to previous diagnostic tests for dry eye diseases. | Q50548182 | ||
| Relation between signs and symptoms of dry eye in the elderly. A population-based perspective. | Q50933029 | ||
| Efficacy and safety of 0.1% cyclosporine A cationic emulsion in the treatment of severe dry eye disease: a multicenter randomized trial. | Q53620228 | ||
| Survey of preferred tests for diagnosis of the tear film and dry eye. | Q54135549 | ||
| Decrease in tear secretion and corneal sensitivity after laser in situ keratomileusis | Q30658995 | ||
| Impact of dry eye syndrome on vision-related quality of life in a non-clinic-based general population | Q31072475 | ||
| Relation between corneal innervation with confocal microscopy and corneal sensitivity with noncontact esthesiometry in patients with dry eye. | Q33267971 | ||
| Changes in corneal epithelial layer inflammatory cells in aqueous tear-deficient dry eye. | Q33486416 | ||
| Characterization of effector T cells in dry eye disease | Q34065949 | ||
| Diagnosing the severity of dry eye: a clear and practical algorithm | Q34092386 | ||
| Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group | Q34523084 | ||
| Dry eye as a mucosal autoimmune disease | Q34647761 | ||
| In vivo confocal evaluation of the ocular surface morpho-functional unit in dry eye. | Q34719893 | ||
| Topical cyclosporine A in the treatment of dry eye: a systematic review and meta-analysis | Q35166231 | ||
| Grading Of Corneal and Conjunctival Staining in the Context of Other Dry Eye Tests | Q35542950 | ||
| Impact of dry eye syndrome on vision-related quality of life | Q35741609 | ||
| Successfully improving ocular drug delivery using the cationic nanoemulsion, novasorb | Q35854966 | ||
| The potential of lipid emulsion for ocular delivery of lipophilic drugs | Q35857091 | ||
| Ocular pharmacokinetics and safety of ciclosporin, a novel topical treatment for dry eye. | Q36068686 | ||
| In Vitro Inhibition of NFAT5-Mediated Induction of CCL2 in Hyperosmotic Conditions by Cyclosporine and Dexamethasone on Human HeLa-Modified Conjunctiva-Derived Cells | Q36093656 | ||
| JNK and ERK MAP kinases mediate induction of IL-1beta, TNF-alpha and IL-8 following hyperosmolar stress in human limbal epithelial cells | Q36380244 | ||
| Dysfunctional tear syndrome: a Delphi approach to treatment recommendations | Q36653052 | ||
| Dry eye disease: an immune-mediated ocular surface disorder | Q36916372 | ||
| Clinical trials in dry eye in surgery for dry eye? | Q37153471 | ||
| Advances in understanding and managing dry eye disease | Q37206550 | ||
| Topical ophthalmic cyclosporine: pharmacology and clinical uses | Q37473764 | ||
| Minimal clinically important difference for the ocular surface disease index | Q37672025 | ||
| In vivo confocal microscopy of corneal nerves: analysis and clinical correlation | Q37810922 | ||
| Role of hyperosmolarity in the pathogenesis and management of dry eye disease: proceedings of the OCEAN group meeting | Q38151227 | ||
| Clinical staining of the ocular surface: mechanisms and interpretations. | Q38280774 | ||
| Efficacy and Safety of Topical 0.05% Cyclosporine Eye Drops in the Treatment of Dry Eye Syndrome: A Systematic Review and Meta-analysis | Q38516740 | ||
| Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group | Q40765221 | ||
| A comparison of cyclosporine 0.05% ophthalmic emulsion versus vehicle in Chinese patients with moderate to severe dry eye disease: an eight-week, multicenter, randomized, double-blind, parallel-group trial | Q42941533 | ||
| Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy | Q43228564 | ||
| P433 | issue | 4 | |
| P921 | main subject | cyclosporine | Q367700 |
| eye disease | Q3041498 | ||
| P304 | page(s) | 577-586 | |
| P577 | publication date | 2017-02-01 | |
| P1433 | published in | Ocular Immunology and Inflammation | Q15760486 |
| P1476 | title | Keratitis in Dry Eye Disease and Topical Ciclosporin A. | |
| P478 | volume | 25 |
| Q41442733 | A comparative review of Haute Autorité de Santé and National Institute for Health and Care Excellence health technology assessments of Ikervis® to treat severe keratitis in adult patients with dry eye disease which has not improved despite treatment |
| Q93139696 | Effects of Vitamin A on Expressions of Apoptosis Genes Bax and Bcl-2 in Epithelial Cells of Corneal Tissues Induced by Benzalkonium Chloride in Mice with Dry Eye |
| Q90403125 | Role of tear film biomarkers in the diagnosis and management of dry eye disease |
Search more.